CervoMed CRVO
NASDAQ CRVO
$1.77 +0.40 (+29.20%)
At close: Nov 11, 2026 · 4:00 PM EST

CervoMed (CRVO) Gross Profit (2010 - 2013)

Updated

CervoMed (CRVO) reported Gross Profit of $71,667 for Q2 2013, down 49.7% from $142,484 a year earlier.

Analysis

CervoMed (CRVO) Gross Profit (2010 - 2013) Analysis & Trends

For FY2012, CervoMed posted Gross Profit of $138,739.

  • By year, Gross Profit came in at -$1.74 million in FY2011 and -$170,204 in FY2010.
  • The Q2 2013 figure ranks as the lowest quarterly Gross Profit since Q1 2012.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 CervoMed 20.73 Mn -57.60 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2013 71,667.00
Sep 30, 2012 142,484.00
Jun 30, 2012 142,484.00
Mar 31, 2012 -68,960.00
Dec 31, 2011 -1.73 Mn
Sep 30, 2011 -3,609.00
Dec 31, 2010 -170,000.00
API Access

CervoMed Gross Profit API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-profit&ticker=CRVO&period=max&api_key=YOUR_API_KEY